Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Therapeutic Delivery|July 28, 2012
Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspectiveMargaret S Landis, Tracey Boyden, Simon PeggCurrent Drug Discovery Technologies|April 26, 2011
Current advances in delivery of biotherapeutics across the blood-brain barrierManoj Rajadhyaksha, Tracey Boyden, Jennifer Liras, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 21, 2008
Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544439 in plasma and urine of humansDeepak Dalvie, Theresa Cosker, Tracey Boyden, et al.Drug Development and Industrial Pharmacy|May 27, 2015
Inhaled PYY(3-36) dry-powder formulation for appetite suppressionPhilip J Kuehl, Tracey Boyden, Dan E Dobry, et al.Biopharmaceutics & Drug Disposition|February 24, 2023
Investigating CNS distribution of PF-05212377, a P-glycoprotein substrate, by translation of 5-HT6 receptor occupancy from non-human primates to humansAarti Sawant-Basak, Laigao Chen, Peter Lockwood, et al.Journal of Medicinal Chemistry|January 3, 2018
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical CandidateChristopher J Helal, Eric Arnold, Tracey Boyden, et al.Pageof 1